Literature DB >> 3947585

Census based mortality study of pharmaceutical industry workers.

J M Harrington, P Goldblatt.   

Abstract

This study was designed to investigate whether the mortality of British pharmaceutical industry workers showed any evidence of occupationally related patterns associated with particular sections of the industry with special emphasis on cancers and respiratory diseases. The data were extracted from census schedules by the Office of Population Censuses and Surveys using occupational categories recorded by pharmaceutical workers at the 1961 and 1971 censuses of England and Wales. Subsequent mortality was ascertained through the National Health Service Central Registry. Both cohorts, followed up to the end of 1981, showed a "healthy worker effect," with overall SMRs ranging from 0.77 to 1.04, though comparison with the employed populations of the longitudinal study reduced this effect by 25%. Evidence of inconsistent excess mortality was noted in small numbers for suicide (SMR 0.91 to 2.79) and cancer of the large intestine (SMR 1.09 to 2.38). There was no clear association between the type of industry and the causes of death investigated. Although the census based study has several methodological shortcomings, there was no evidence, on the basis of this study, to suggest any excess mortality risk from employment in the pharmaceutical industry.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947585      PMCID: PMC1007634          DOI: 10.1136/oem.43.3.206

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  9 in total

1.  Standardized mortality ratios and the "healthy worker effect": Scratching beneath the surface.

Authors:  A J McMichael
Journal:  J Occup Med       Date:  1976-03

2.  [Occupational exposure to drugs. General considerations].

Authors:  L Alessio; S Banderali; G Farina
Journal:  Med Lav       Date:  1976 May-Jun       Impact factor: 1.275

3.  Selection and mortality differentials.

Authors:  A J Fox; P O Goldblatt; A M Adelstein
Journal:  J Epidemiol Community Health       Date:  1982-06       Impact factor: 3.710

4.  The occupational hazards of formulating oral contraceptives--a survey of plant employees.

Authors:  J M Harrington; G F Stein; R O Rivera; A V de Morales
Journal:  Arch Environ Health       Date:  1978 Jan-Feb

5.  Occupational mortality studies. Principles of validity.

Authors:  J D Wang; O S Miettinen
Journal:  Scand J Work Environ Health       Date:  1982-09       Impact factor: 5.024

6.  Mortality among workers employed in the pharmaceutical industry: a preliminary investigation.

Authors:  T L Thomas; P Decoufle
Journal:  J Occup Med       Date:  1979-09

7.  Adrenocortical suppression in workers employed in manufacturing synthetic glucocorticosteroids: solutions to a problem.

Authors:  R W Newton; M C Browning; P C Nicholson; D A Mowat
Journal:  Br J Ind Med       Date:  1982-05

8.  Census-based mortality study of fertiliser manufactures.

Authors:  P Fraser; C Chilvers; P Goldblatt
Journal:  Br J Ind Med       Date:  1982-11

9.  Mortality study of British pathologists 1974-80.

Authors:  J M Harrington; D Oakes
Journal:  Br J Ind Med       Date:  1984-05
  9 in total
  4 in total

1.  Occupational mortality of women aged 15-59 years at death in England and Wales.

Authors:  K A Moser; P O Goldblatt
Journal:  J Epidemiol Community Health       Date:  1991-06       Impact factor: 3.710

Review 2.  Occupational risk factors for female breast cancer: a review.

Authors:  M S Goldberg; F Labrèche
Journal:  Occup Environ Med       Date:  1996-03       Impact factor: 4.402

Review 3.  Occupational exposures and colorectal cancers: a quantitative overview of epidemiological evidence.

Authors:  Enrico Oddone; Carlo Modonesi; Gemma Gatta
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 4.  Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.

Authors:  Bénédicte Clin; Jean-Claude Pairon
Journal:  BMC Public Health       Date:  2014-11-06       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.